menu
    • menu

    Company profile for Melior Pharmaceuticals

    NEW Drugs in Dev: 2
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Melior Discovery is a world class provider of in vivo pharmacology services. We evaluate candidate therapeutics in animal models of human disease. The company has established and validated over 80 animal models in an array of therapeutic areas such as inflammation, immunology, diabetes & metabolic syndrome, dermatology, cardiovascular, gastrointestinal, psychiatric, neurological and neurodegenerative disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Melior PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Melior Discovery Inc. 860 Springdale Drive Suite 500 Exton, PA 19341
    Telephone
    Telephone
    (610) 280-0633
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.meliordiscovery.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/melior-discovery
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Melior Pharmaceuticals Announces Execution of License Agreement
    Melior Pharmaceuticals Announces Execution of License Agreement

    29 Jul 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210729005267/en

    BUSINESSWIRE
    29 Jul 2021
    Share Share
    Melior has signed a “letter of intent” with Adhera Therapeutics
    Melior has signed a “letter of intent” with Adhera Therapeutics

    07 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210607005131/en/Melior-Pharmaceuticals-Announces-Entry-Into-%E2%80%9CLetter-of-Intent%E2%80%9D-for-the-Acquisition-of-Armesocarb-by-Adhera-Therapeutics

    BUSINESSWIRE
    07 Jun 2021
    Share Share
    Melior Pharmaceuticals to initiate trial of Covid-19 drug
    Melior Pharmaceuticals to initiate trial of Covid-19 drug

    10 Mar 2021

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/melior-pharmaceuticals-trial-drug/

    CLINICALTRIALSARENA
    10 Mar 2021
    Share Share
    Melior Receives IND Clearance from US FDA for COVID-19 Therapeutic
    Melior Receives IND Clearance from US FDA for COVID-19 Therapeutic

    09 Mar 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210309005144/en

    BUSINESSWIRE
    09 Mar 2021
    Share Share
    Melior Receives IND Clearance from US FDA for COVID-19 Therapeutic
    Melior Receives IND Clearance from US FDA for COVID-19 Therapeutic

    09 Mar 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210309005144/en/Melior-Pharmaceuticals-Receives-IND-Clearance-from-US-FDA-for-COVID-19-Therapeutic

    BUSINESSWIRE
    09 Mar 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search